Qingdao Baheal Medical (SZSE:301015) 3-Year EBITDA Growth Rate : 24.40% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Qingdao Baheal Medical 3-Year EBITDA Growth Rate?

Qingdao Baheal Medical's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.43.

During the past 12 months, Qingdao Baheal Medical's average EBITDA Per Share Growth Rate was 27.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 24.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Qingdao Baheal Medical was 24.90% per year. The lowest was 12.70% per year. And the median was 18.00% per year.

Competitive Comparison of Qingdao Baheal Medical's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Qingdao Baheal Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qingdao Baheal Medical's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qingdao Baheal Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Qingdao Baheal Medical's 3-Year EBITDA Growth Rate falls into.

Qingdao Baheal Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Qingdao Baheal Medical (SZSE:301015) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Qingdao Baheal Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Qingdao Baheal Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Baheal Medical (SZSE:301015) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qingdao Baheal Medical Inc (SZSE:301015) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 88 Kaifeng Road, Shibei District, Shandong Province, Qingdao, CHN, 266042

Website

http://www.baheal.cn

Qingdao Baheal Medical Inc is engaged in providing comprehensive marketing services for pharmaceutical product manufacturers.

Qingdao Baheal Medical (SZSE:301015) Headlines

No Headlines